Trials / Completed
CompletedNCT00653276
MD Ezetimibe Cyclosporine Interaction (0653-057)
An Open-Label, 2-Period, Crossover Study to Determine the Effect of Multiple Oral Doses of Ezetimibe 20 mg on the Pharmacokinetics of a Single Oral Dose of Cyclosporine in Young, Healthy, Normal, Male and Female Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Study to determine the effect of multiple oral doses of ezetimibe on the pharmacokinetics of a single oral dose cyclosporine in young healthy males and females.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ezetimibe | ezetimibe 20 mg (2 x 10 mg tablets) on Days 1 through Day 7. |
| DRUG | Comparator: cyclosporine | single oral dose of cyclosporine 100 mg capsules on Day 1 or Day 7. |
Timeline
- Start date
- 2003-11-01
- Primary completion
- 2004-01-01
- Completion
- 2004-01-01
- First posted
- 2008-04-04
- Last updated
- 2024-08-15
Source: ClinicalTrials.gov record NCT00653276. Inclusion in this directory is not an endorsement.